Loading stock data…
Elicio Therapeutics, Inc. (ELTX)
$3.00-0.15 (-4.76%)
Market ClosedLast close Jul 24
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Elicio Therapeutics, Inc. in the Healthcare sector is trading at $3.00 with a market capitalization of $239M. Wall Street consensus targets $20.00 (3 analysts), implying a +566.7% move over the next 12 months. The stock is currently near its 52-week low of $2.66, remaining 66.7% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +566.7% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$10.60M↓ | -$8.84M↓ | -$8.04M↑ | -$9.68M↑ | -$10.74M |
| Net Income | -$11.82M↓ | -$7.72M↑ | -$10.08M↑ | -$10.56M↑ | -$11.21M |
Peer Comparison
JNJUNHPFE
Fundamentals
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II cl...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$239.15M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
2796.45%
Volume
Today's trading volume
247,043
Recent News
Wall Street Set to Open Higher in Thursday Trading; US Adds Only 57,000 Jobs in June
US stocks look set to open higher in Thursday's trading session as investors parse key employment da
Another Blow For ELTX? Elicio Raises Fresh Capital Weeks After Trial Disappointment
Elicio Therapeutics expects to generate net proceeds of about $15 million from the stock offering.
This Monthly Dividend Powerhouse Is Trading at a Bargain-Bin Valuation
EPR Properties offers income investors a rare combination: a 6.3% monthly dividend yield, a conservative 73% payout ratio, and diversified exposure to experiential real estate well beyond movie theatres, trading at just 10.7x FFO.
Stocks Settle Sharply Higher as US-Iran Peace Deal Spurs Optimism
The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.65%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.92%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +3.06%. June E-mini S&P futures (ESM26 ) rose +1.68%, and June E-mini Nasdaq futures...
Sector Update: Healthcare Stocks Softer Late Afternoon
Healthcare stocks declined late Monday afternoon with the NYSE Healthcare Index decreasing 0.6% and